Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fixed-Dose vs Concentration-Adjusted Lopinavir/Ritonavir in HIV Salvage Therapy
NCT00046033Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Primary completion
- Mar 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00046033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00046033.